Avidity Biosciences (RNA) News Today $48.84 +2.23 (+4.77%) As of 10:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD444 hours ago | prnewswire.comTroy Edward Wilson Sells 29,500 Shares of Avidity Biosciences (NASDAQ:RNA) Stock5 hours ago | insidertrades.comCantor Fitzgerald Reiterates a Buy Rating on Avidity Biosciences (RNA)September 10 at 3:11 AM | insidermonkey.comAvidity Biosciences, Inc. (RNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8 at 5:35 PM | seekingalpha.comAlyeska Investment Group L.P. Has $2.95 Million Stock Holdings in Avidity Biosciences, Inc. $RNASeptember 8 at 5:14 AM | marketbeat.comRaymond James Financial Inc. Sells 39,643 Shares of Avidity Biosciences, Inc. $RNASeptember 8 at 3:20 AM | marketbeat.comAvidity Biosciences, Inc. (RNA) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7 at 11:01 PM | seekingalpha.comAvidity Biosciences’ Promising Phase 3 Study on Del-desiran for DM1: What Investors Need to KnowSeptember 7 at 5:20 PM | msn.comEFG Asset Management North America Corp. Raises Stock Holdings in Avidity Biosciences, Inc. $RNASeptember 6, 2025 | marketbeat.comEric Mosbrooker Sells 6,563 Shares of Avidity Biosciences (NASDAQ:RNA) StockSeptember 6, 2025 | insidertrades.comAvidity Biosciences, Inc. $RNA Shares Sold by Cormorant Asset Management LPSeptember 6, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $63.35 Million Stock Position in Avidity Biosciences, Inc. $RNASeptember 5, 2025 | marketbeat.comAvidity Biosciences, Inc. (RNA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 5, 2025 | seekingalpha.comMPM Bioimpact LLC Has $21.08 Million Stake in Avidity Biosciences, Inc. $RNASeptember 4, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Invests $15.50 Million in Avidity Biosciences, Inc. $RNASeptember 4, 2025 | marketbeat.comAvidity Biosciences CEO expects ‘lots of rumors’ about acquisition interestSeptember 4, 2025 | msn.comNorthern Trust Corp Sells 60,952 Shares of Avidity Biosciences, Inc. $RNASeptember 2, 2025 | marketbeat.comDriehaus Capital Management LLC Purchases 42,873 Shares of Avidity Biosciences, Inc. $RNAAugust 31, 2025 | marketbeat.comSiren L.L.C. Decreases Holdings in Avidity Biosciences, Inc. $RNAAugust 31, 2025 | marketbeat.comRafferty Asset Management LLC Sells 32,167 Shares of Avidity Biosciences, Inc. $RNAAugust 31, 2025 | marketbeat.comInsider Selling: Avidity Biosciences (NASDAQ:RNA) CEO Sells 25,000 Shares of StockAugust 30, 2025 | insidertrades.comInvesco Ltd. Purchases 193,376 Shares of Avidity Biosciences, Inc. $RNAAugust 28, 2025 | marketbeat.comAvidity Biosciences to Participate in Upcoming Investor ConferencesAugust 27, 2025 | prnewswire.comBI Asset Management Fondsmaeglerselskab A S Sells 52,463 Shares of Avidity Biosciences, Inc. $RNAAugust 27, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Purchases 295,275 Shares of Avidity Biosciences, Inc. $RNAAugust 26, 2025 | marketbeat.com771,158 Shares in Avidity Biosciences, Inc. $RNA Acquired by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comNuveen LLC Invests $12.73 Million in Avidity Biosciences, Inc. $RNAAugust 24, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Insider Sells $102,451.20 in StockAugust 23, 2025 | insidertrades.comCandriam S.C.A. Increases Stock Position in Avidity Biosciences, Inc. $RNAAugust 23, 2025 | marketbeat.comWellington Management Group LLP Has $285.89 Million Stock Holdings in Avidity Biosciences, Inc. $RNAAugust 22, 2025 | marketbeat.comAberdeen Group plc Increases Holdings in Avidity Biosciences, Inc. $RNAAugust 22, 2025 | marketbeat.comAvidity Biosciences, Inc. $RNA Shares Sold by Swiss National BankAugust 22, 2025 | marketbeat.comAvidity Biosciences Sees Unusually High Options Volume (NASDAQ:RNA)August 21, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Trading Down 4.2% on Insider SellingAugust 20, 2025 | marketbeat.comAvidity Biosciences, Inc. $RNA Holdings Cut by Vanguard Group Inc.August 19, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Citigroup Inc.August 18, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Deutsche Bank AGAugust 18, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $465,600.00 in StockAugust 17, 2025 | marketbeat.comTeresa Mccarthy Sells 10,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockAugust 16, 2025 | insidertrades.comAvidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Recommendation of "Buy" by AnalystsAugust 16, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Shares Gap Down on Insider SellingAugust 12, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for RNA FY2027 Earnings?August 12, 2025 | marketbeat.comMackenzie Financial Corp Invests $213,000 in Avidity Biosciences, Inc. (NASDAQ:RNA)August 11, 2025 | marketbeat.comTroy Edward Wilson Sells 65,554 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Steven George Hughes Sells 81,434 SharesAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Director Sells $5,119,150.00 in StockAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Eric Mosbrooker Sells 130,807 SharesAugust 10, 2025 | marketbeat.comThe Avidity Biosciences, Inc. (NASDAQ:RNA) Second-Quarter Results Are Out And Analysts Have Published New ForecastsAugust 10, 2025 | finance.yahoo.comAvidity (RNA) Q2 Revenue Jumps 88%August 9, 2025 | theglobeandmail.comWells Fargo & Company Issues Positive Forecast for Avidity Biosciences (NASDAQ:RNA) Stock PriceAugust 9, 2025 | marketbeat.com Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RNA Media Mentions By Week RNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNA News Sentiment▼0.890.84▲Average Medical News Sentiment RNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNA Articles This Week▼178▲RNA Articles Average Week Get the Latest News and Ratings for RNA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Ascendis Pharma A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today QIAGEN News Today BridgeBio Pharma News Today Moderna News Today Verona Pharma PLC American Depositary Share News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNA) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
